Enipto, Clark E.
HRN: 40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/07/2022
04/14/2022
IV
175mg
Q6h
AGE With MOD.DHN
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes